pembrolizumab,enfortumab vedotin
merck,astellas
['pembro', 'bladder']
adcs with immune checkpoint inhibition are the next big chapter in bladder cancer. preliminary data suggests type of payload may relevant for a positive interaction with immune checkpoint inhibition. the slide below suggests ev302(ev/pembro) trial will be good #asco22 
Interested in Urology Cancers, biomarkers and drug development.